GlobeNewswire

First Tracks Biotherapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update
03/11/2026
Announced ANB033 achieved a statistically significant and clinically meaningful protective effect on both gluten-induced intestinal damage and symptoms in Cohort 1 (gluten challenge) of Phase 1b trial in celiac disease [...]
Crescent Biopharma Announces Grants of Inducement Awards
03/11/2026
WALTHAM, Mass., Nov. 03, 2026 (GLOBE NEWSWIRE) -- Crescent Biopharma , Inc. (“Crescent” or the “Company”) (Nasdaq: CBIO), a clinical-stage biotechnology company dedicated to rapidly advancing the next wave of therapies [...]
First Tracks Biotherapeutics Announces Participation in Upcoming Investor Conferences
03/11/2026
SAN DIEGO, Nov. 03, 2026 (GLOBE NEWSWIRE) -- First Tracks Biotherapeutics, Inc. (Nasdaq: TRAX), a clinical stage biotechnology company advancing antibody therapeutics that modulate immune pathways implicated in [...]
Elevar Therapeutics Announces Lirafugratinib (Lyrfigtu) Added to NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) as Second-line Therapy for Cholangiocarcinoma with FGFR2 Fusion or Other Rearrangement
03/11/2026
FORT LEE, N.J., Nov. 03, 2026 (GLOBE NEWSWIRE) -- Elevar Therapeutics, Inc., a majority-owned subsidiary of HLB Co., Ltd. and a fully integrated biopharmaceutical company dedicated to elevating treatment experiences and [...]
Xilio Therapeutics to Present at the Stifel 2026 Healthcare Conference
03/11/2026
WALTHAM, Mass., Nov. 03, 2026 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing masked immuno-oncology therapies for people living with cancer [...]
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03/11/2026
SAN FRANCISCO, Nov. 03, 2026 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and [...]
MediWound Announces $15 Million Bought Deal Offering of Ordinary Shares
03/11/2026
MediWound Announces $15 Million Bought Deal Offering of Ordinary Shares YAVNE, Israel, November 3, 2026 (GLOBE NEWSWIRE) — MediWound Ltd. (Nasdaq: MDWD) (“MediWound”), a global leader in next-generation enzymatic [...]
The Menninger Clinic Reports Measurable Improvements Across Multiple Mental Health Outcomes
03/11/2026
HOUSTON, Nov. 03, 2026 (GLOBE NEWSWIRE) -- The Menninger Clinic, a nationally recognized psychiatric hospital, has released its 2025 inpatient treatment outcomes data, documenting measurable improvements in mental [...]
Déclaration d’actions et de droits de vote Statut au 31 octobre 2026
03/11/2026
VALNEVA Déclaration d’actions et de droits de vote Statut au 31 octobre 2026 __________________________________________________________________________________________ Dénomination sociale : VALNEVA Adresse du siège [...]
Declaration of shares and voting rights Status as of October 31, 2026
03/11/2026
VALNEVA Declaration of shares and voting rights Status as of October 31, 2026 __________________________________________________________________________________________ Company name: VALNEVA Registered office: Îlot [...]
Small business benefits made easier: Saskatchewan Blue Cross introduces Business Select®
03/11/2026
Get coverage that clicks. Business Select makes benefits simpler for small Saskatchewan businesses. SASKATOON, Saskatchewan, Nov. 03, 2026 (GLOBE NEWSWIRE) -- When you run a small business, choosing employee benefits [...]
Clinicians with Lobular Breast Cancer Launch National Effort to Raise Awareness and Advocate for Change
03/11/2026
Boston, MA, US, Nov. 03, 2026 (GLOBE NEWSWIRE) -- Despite nearly 50,000 new U.S. diagnoses each year and incidence increasing faster than other breast cancer types, invasive lobular carcinoma (ILC) remains significantly [...]
City Therapeutics to Present at Upcoming November Investor Conferences
03/11/2026
CAMBRIDGE, Mass., Nov. 03, 2026 (GLOBE NEWSWIRE) -- City Therapeutics, Inc. (Nasdaq: CTY), a clinical-stage biotechnology company developing the next generation of RNA interference (RNAi) therapeutics, today announced [...]
Geron Corporation to Participate in the Stifel 2026 Healthcare Conference
03/11/2026
FOSTER CITY, Calif., Nov. 03, 2026 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN), a hematology-focused biopharmaceutical company pursuing more meaningful moments for people living with blood cancer, today [...]
Humacyte Innovative Research in Coronary Bypass and Vascular Regeneration to be Highlighted at American Heart Association Scientific Sessions 2026
03/11/2026
– Founder & CEO Laura Niklason, M.D., Ph.D., to deliver invited talk on engineering the microenvironment to accelerate vascular regeneration. – Two additional presentations to cover first-in-human Phase 2a study [...]
Cabaletta Bio to Participate in Upcoming Investor Conferences
03/11/2026
PHILADELPHIA, Nov. 03, 2026 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (Nasdaq: CABA), a late-stage clinical biotechnology company focused on developing and launching curative targeted cell therapies designed specifically [...]
Avalyn to Present at Upcoming Investor Conferences
03/11/2026
BOSTON, Nov. 03, 2026 (GLOBE NEWSWIRE) -- Avalyn Pharma Inc. (Nasdaq: AVLN), a clinical-stage biopharmaceutical company pioneering inhaled therapies to transform the treatment paradigm of serious, rare respiratory [...]
Bolt Biotherapeutics to Participate in Upcoming Conferences
03/11/2026
REDWOOD CITY, Calif., Nov. 03, 2026 (GLOBE NEWSWIRE) -- Bolt Biotherapeutics, Inc. (Nasdaq: BOLT) (“Bolt” or the “Company”), a clinical-stage biotechnology company pioneering a new generation of half-life-extended [...]
4DMT to Participate in Upcoming Investor Conferences
03/11/2026
EMERYVILLE, Calif., Nov. 03, 2026 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with [...]

Pages

Other news

Test 2

Lorem ipsum

Test 1

Lorem upsum